The impact of new drugs and the changing role of transplants in multiple myeloma
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.
How can standard risk multiple myeloma (MM) patients be cured?
Management of transplant-eligible myeloma patients in 2017
The epigenetics of multiple myeloma and the rationale for HDAC inhibitors